Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States Academic Article uri icon


MeSH Major

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Proteome
  • Urinary Bladder Neoplasms


  • Hemi-ablation of the prostate with WST11 vascular targeted photodynamic therapy was well tolerated and resulted in a negative biopsy in the treated lobe in the majority of men. Dosing parameters and the light dose index appear related to tissue response as determined by magnetic resonance imaging and biopsy. These parameters may serve as the basis for further prospective studies.

publication date

  • January 2016



  • Academic Article



  • eng

PubMed Central ID

  • PMC5483996

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2016.05.113

PubMed ID

  • 27291652

Additional Document Info

start page

  • 1096

end page

  • 104